IP Library Patent Application 18142413
Patent Application
App. No. 18/142,413

CONSTRUCTS AND USES THEREOF FOR EFFICIENT AND SPECIFIC GENOME EDITING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/142,413
Abstract

A composition comprising a CRISPR nuclease, where the nuclease includes a sequence with at least 60% sequence identity to any one of SEQ ID NOs: 143-177 and 229, optionally also including a guide nucleic acid (gNA), such as a guide ribonucleic acid (gRNA) and, in some cases, a donor sequence. Also include are methods of creating a strand break at or near a target sequence in a target polynucleotide by contacting the target polynucleotide with a nuclease including a sequence with at least 60% sequence identity to any one of SEQ ID NOs: 143-177 and 229, and a compatible guide nucleic acid (gNA), such as a guide ribonucleic acid (gRNA).

Claims (42)

1 .- 46 . (canceled)

47 . A composition comprising:

(i) an engineered nucleic acid-guided nuclease comprising an engineered nuclease polypeptide comprising an amino acid sequence having at least 90% sequence identity to any one of SEQ ID NO: 143-177 and 229, or a polynucleotide or polynucleotides encoding an amino acid sequence having at least 90% sequence identity to any one of SEQ ID NO: 143-177 and 229.

48 . The composition of claim 47 comprising an engineered nuclease polypeptide comprising an amino acid sequence having at least 90% sequence identity to any one of SEQ ID NO: 144, 153, and 229, or a polynucleotide or polynucleotides encoding an amino acid sequence having at least 90% sequence identity to any one of SEQ ID NO: 144, 153, and 229.

49 . The composition of claim 47 comprising an engineered nuclease polypeptide comprising an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 144 or a polynucleotide or polynucleotides encoding an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 144.

50 . The composition of claim 47 comprising an engineered nuclease polypeptide comprising an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 153 or a polynucleotide or polynucleotides encoding an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 153.

51 . The composition of claim 47 comprising an engineered nuclease polypeptide comprising an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 229 or a polynucleotide or polynucleotides encoding an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 229.

52 . The composition of claim 47 wherein the sequence identity is at least 95%.

53 . The composition of claim 47 wherein the sequence identity is at least 99%.

54 . The composition of claim 47 wherein the sequence identity is 100%.

55 . The composition of claim 47 wherein the engineered nuclease polypeptide does not contain the peptide motif YLFQIYNKDF (SEQ ID NO. 224) or a polynucleotide or polynucleotides encoding the engineered nuclease polypeptide that does not contain the peptide motif YLFQIYNKDF (SEQ ID NO. 224).

56 . The composition of claim 47 further comprising:

(ii) a compatible guide nucleic acid, wherein the nucleic acid-guided nuclease is complexed with guide nucleic acid to form a nucleic acid-guided nuclease complex.

57 . The composition of claim 56 wherein the guide nucleic acid is a gRNA and the complex is an RNP.

58 . The composition of claim 56 wherein the guide nucleic acid is a dual guide nucleic acid.

59 . The composition of claim 56 wherein the guide nucleic acid is an engineered guide nucleic acid.

60 . The composition of claim 56 wherein the guide nucleic acid comprises any one of SEQ ID NO: 291-325, or a portion thereof.

61 . The composition of claim 56 wherein the guide nucleic acid is a synthetic guide nucleic acid.

62 . The composition of claim 56 wherein the guide nucleic acid comprises one or more chemical modifications.

63 . A method of creating a strand break at or near a target sequence in a target polynucleotide comprising contacting the target polynucleotide with a nucleic acid-guided nuclease complex comprising

(i) an engineered nucleic acid-guided nuclease comprising an engineered nuclease polypeptide comprising an amino acid sequence having at least 90% sequence identity to any one of SEQ ID NO: 143-177 and 229, and

(ii) a compatible guide nucleic acid, wherein

(a) the nucleic acid-guided nuclease is complexed with guide nucleic acid to form a nucleic acid-guided nuclease complex, and

(b) wherein the compatible guide nucleic acid of the complex targets the target sequence;

and allowing the nucleic acid-guided nuclease complex to create the strand break.

64 . The method of claim 63 wherein the nucleic acid-guided nuclease complex comprises an engineered nuclease polypeptide comprising an amino acid sequence having at least 90% sequence identity to any one of SEQ ID NO: 144, 153, and 229.

65 . The method of claim 63 wherein the nucleic acid-guided nuclease complex comprises an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 144.

66 . The method of claim 63 wherein the nucleic acid-guided nuclease complex comprises an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 153.

67 . The method of claim 63 wherein the nucleic acid-guided nuclease complex comprises an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 229.

68 . A composition comprising an engineered polynucleotide or polynucleotides comprising one or more polynucleotides comprising a sequence corresponding to a sequence with at least 90% sequence identity to any one of SEQ ID NO: 1-142 and 225-228.

69 . The composition of claim 68 comprising one or more polynucleotides comprising a sequence corresponding to a sequence with at least 90% sequence identity to any one of SEQ ID NO: 1, 5, 11, 15, 19, 23, 27, 31, 35, 39, 43, 47, 51, 55, 59, 63, 67, 71, 75, 79, 83, 87, 91, 95, 99, 103, 107, 111, 115, 119, 123, 127, 131, 135, 139, and 225.

70 . The composition of claim 68 wherein the polynucleotide codes for one or more additional amino acid sequences at either the N-terminus, the C-terminus or both, of a polypeptide encoded by the polynucleotide, wherein the additional amino acid sequences comprise at least one of

(i) one or more NLSs;

(ii) one or more purification tags;

(iii) one or cleavage sequences; and

(iv) FLAG or 3×FLAG.

71 . The composition of claim 68 wherein the polynucleotide or polynucleotides are codon optimized for E. coli.

72 . The composition of claim 68 wherein the polynucleotide or polynucleotides are codon optimized for S. cerevisiae.

73 . The composition of claim 68 wherein the polynucleotide or polynucleotides are codon optimized for human.

74 . The composition of claim 68 wherein the sequence identity is at least 95%.

75 . The composition of claim 68 wherein the sequence identity is at least 99%.

76 . The composition of claim 68 wherein the sequence identity is 100%.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Aug 23, 2024
From: FIRST-CITIZENS BANK & TRUST COMPANY
To: ARTISAN DEVELOPMENT LABS, INC.
Reel/Frame 068378/0660 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2024
From: ARTISAN (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
To: CELYNTRA THERAPEUTICS SA
Reel/Frame 068379/0682 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2024
From: ARTISAN DEVELOPMENT LABS, INC.
To: ARTISAN (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Reel/Frame 068763/0799 →
SECURITY INTEREST Recorded Jul 31, 2023
From: ARTISAN DEVELOPMENT LABS, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
Reel/Frame 064442/0952 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2023
From: KERSHNER, JAMIE; LIU, RONGMING; LIANG, LIYA; BAUMGARTNER, ROLAND; WARNECKE, TANYA
To: ARTISAN DEVELOPMENT LABS, INC.
Reel/Frame 063544/0653 →